Skip to main content

Fernàndez Garberi, Caterina

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Fernàndez Garberi, Caterina

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Related news

The project will analyse the functional activation of the NLRP3 inflammasome to advance the early identification of patients at risk of insufficient response to S1P receptor-modulating therapies.

Anti-Müllerian hormone had been proposed as a potential biomarker for predicting disease prognosis in women, but this study shows that the observed association is explained by patients’ chronological age.

The Spider-MS tool estimates the probability that a patient will experience various long-term clinical events and will help personalize the follow-up and treatment of each person living with the disease.

Related professionals

Estefania De la Torre Villaescusa

Estefania De la Torre Villaescusa

Cap d'Unitat
Teaching Unit
Internal Strategy Directorate
Read more
Anna Llort Sales

Anna Llort Sales

Main researcher
Childhood Cancer and Blood Disorders
Read more
Maria Pilar Delgado Martínez

Maria Pilar Delgado Martínez

Main researcher
Neurovascular Diseases
Read more
Carlos Hobeich Naya

Carlos Hobeich Naya

Research technician
Transfusional Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.